{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:16:47Z","timestamp":1788225407669,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunological biomarkers are increasingly relevant for personalized cancer treatment, but peripheral blood-derived biomarkers are not yet used to guide therapy in head and neck squamous cell carcinoma (HNSCC). The prospective non-randomized DIREKHT study (ClinicalTrials.gov: NCT02528955, 2015-08-19) therefore integrated immune monitoring into postoperative radio(chemo)therapy (R(C)T) to explore blood-based biomarkers. In 70 oral cavity and oropharyngeal cancer patients receiving curative R(C)T, the peripheral immune status was assessed before and after therapy and during follow-up by flow cytometry-based immunophenotyping of 45 immune parameters. A machine learning workflow identified predictors of disease-free survival (DFS), using Repeated Elastic Net Technique (RENT) feature selection within repeated stratified K-fold cross-validation and nested cross-validation for tuning and assessment. This approach identified a 29-parameter immune signature from pre- and post-therapeutic profiles, with key contributors including HLA-DR\u2009+\u2009T cells, HLA-DR+ monocytes, and basophils. The best model achieved a Matthews correlation coefficient of 0.681, with pre- and post-therapeutic parameters contributing equally, highlighting immune dynamics during R(C)T. Adding clinical parameters did not improve performance (MCC\u2009=\u20090.678), but yielded a comparable model integrating immune and clinical variables. Blood-based immune signatures may have prognostic relevance for DFS after R(C)T in HNSCC. Validation in larger cohorts is required to confirm clinical applicability and reduce the signature.<\/jats:p>","DOI":"10.1038\/s41698-026-01658-w","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:24:06Z","timestamp":1788175446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploratory immunomonitoring during radiochemotherapy in HNSCC and machine-learning reveal immune parameters associated with disease-free survival"],"prefix":"10.1038","volume":"10","author":[{"given":"Anna-Jasmina","family":"Donaubauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Mogge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina K.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia Marie","family":"Futsaether","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian Hovde","family":"Liland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao Ngoc","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"von der Gr\u00fcn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Balermpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Fleischmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias G.","family":"Hautmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Steger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Stromberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Budach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schymalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Engenhart-Cabillic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Kocik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Geinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Nestle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Klautke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Scherl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Corradini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Fietkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udo S.","family":"Gaipl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlen","family":"Haderlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"1658_CR1","doi-asserted-by":"publisher","unstructured":"Barsouk, A., Aluru, J. S., Rawla, P., Saginala, K. & Barsouk, A. Epidemiology, risk factors, and prevention of head and neck squamous cell carcinoma. Med. Sci. 11, https:\/\/doi.org\/10.3390\/medsci11020042 (2023).","DOI":"10.3390\/medsci11020042"},{"key":"1658_CR2","unstructured":"Krebsgesellschaft, D. Kopf-Hals-Tumoren - \u00dcberblick, https:\/\/www.krebsgesellschaft.de\/onko-internetportal\/basis-informationen-krebs\/krebsarten\/andere-krebsarten\/kopf-hals-tumoren.html (2023)."},{"key":"1658_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41572-020-00224-3","volume":"6","author":"DE Johnson","year":"2020","unstructured":"Johnson, D. E. et al. Head and neck squamous cell carcinoma. Nat. Rev. Dis. Prim. 6, 92 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1658_CR4","doi-asserted-by":"publisher","unstructured":"Zhou, J. G. et al. Prospective development and validation of a liquid immune profile-based signature (LIPS) to predict response of patients with recurrent\/metastatic cancer to immune checkpoint inhibitors. J. Immunother Cancer 9, https:\/\/doi.org\/10.1136\/jitc-2020-001845 (2021).","DOI":"10.1136\/jitc-2020-001845"},{"key":"1658_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/978-3-030-38862-1_9","volume":"180","author":"JA Chen","year":"2020","unstructured":"Chen, J. A., Ma, W., Yuan, J. & Li, T. Translational biomarkers and rationale strategies to overcome resistance to immune checkpoint inhibitors in solid tumors. Cancer Treat. Res. 180, 251\u2013279 (2020).","journal-title":"Cancer Treat. Res."},{"key":"1658_CR6","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.semcancer.2018.01.008","volume":"52","author":"B Solomon","year":"2018","unstructured":"Solomon, B., Young, R. J. & Rischin, D. Head and neck squamous cell carcinoma: genomics and emerging biomarkers for immunomodulatory cancer treatments. Semin Cancer Biol. 52, 228\u2013240 (2018).","journal-title":"Semin Cancer Biol."},{"key":"1658_CR7","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(19)32591-7","volume":"394","author":"B Burtness","year":"2019","unstructured":"Burtness, B. et al. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study. Lancet 394, 1915\u20131928 (2019).","journal-title":"Lancet"},{"key":"1658_CR8","doi-asserted-by":"publisher","unstructured":"Runnels, J. et al. Combining Radiotherapy and Immunotherapy in Head and Neck Cancer. Biomedicines 11, https:\/\/doi.org\/10.3390\/biomedicines11082097 (2023).","DOI":"10.3390\/biomedicines11082097"},{"key":"1658_CR9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJMoa2415434","volume":"393","author":"R Uppaluri","year":"2025","unstructured":"Uppaluri, R. et al. Neoadjuvant and adjuvant pembrolizumab in locally advanced head and neck cancer. N. Engl. J. Med. 393, 37\u201350 (2025).","journal-title":"N. Engl. J. Med."},{"key":"1658_CR10","doi-asserted-by":"publisher","first-page":"LBA2","DOI":"10.1200\/JCO.2025.43.17_suppl.LBA2","volume":"43","author":"J Bourhis","year":"2025","unstructured":"Bourhis, J. et al. NIVOPOSTOP (GORTEC 2018-01): a phase III randomized trial of adjuvant nivolumab added to radio-chemotherapy in patients with resected head and neck squamous cell carcinoma at high risk of relapse. J. Clin. Oncol. 43, LBA2\u2013LBA2 (2025).","journal-title":"J. Clin. Oncol."},{"key":"1658_CR11","doi-asserted-by":"publisher","first-page":"100944","DOI":"10.1016\/j.neo.2023.100944","volume":"45","author":"F Grottker","year":"2023","unstructured":"Grottker, F. et al. Radiotherapy combined with docetaxel alters the immune phenotype of HNSCC cells and results in increased surface expression of CD137 and release of HMGB1 of specifically HPV-positive tumor cells. Neoplasia 45, 100944 (2023).","journal-title":"Neoplasia"},{"key":"1658_CR12","doi-asserted-by":"publisher","unstructured":"Wimmer, S. et al. Hypofractionated radiotherapy upregulates several immune checkpoint molecules in head and neck squamous cell carcinoma cells independently of the HPV status while ICOS-L is upregulated only on HPV-positive cells. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22179114 (2021).","DOI":"10.3390\/ijms22179114"},{"key":"1658_CR13","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1158\/1078-0432.CCR-18-1449","volume":"25","author":"KH Kim","year":"2019","unstructured":"Kim, K. H. et al. The first-week proliferative response of peripheral blood PD-1(+)CD8(+) T cells predicts the response to anti-PD-1 therapy in solid tumors. Clin. Cancer Res. 25, 2144\u20132154 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1658_CR14","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/bs.mie.2019.03.003","volume":"632","author":"AJ Donaubauer","year":"2020","unstructured":"Donaubauer, A. J. et al. Analysis of the immune status from peripheral whole blood with a single-tube multicolor flow cytometry assay. Methods Enzymol. 632, 389\u2013415 (2020).","journal-title":"Methods Enzymol."},{"key":"1658_CR15","doi-asserted-by":"publisher","first-page":"100953","DOI":"10.1016\/j.neo.2023.100953","volume":"49","author":"M Hecht","year":"2024","unstructured":"Hecht, M. et al. Machine Learning-assisted immunophenotyping of peripheral blood identifies innate immune cells as best predictor of response to induction chemo-immunotherapy in head and neck squamous cell carcinoma - knowledge obtained from the CheckRad-CD8 trial. Neoplasia 49, 100953 (2024).","journal-title":"Neoplasia"},{"key":"1658_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00262-024-03810-6","volume":"73","author":"J von der Grun","year":"2024","unstructured":"von der Grun, J., Broglie, M., Guckenberger, M. & Balermpas, P. A comprehensive and longitudinal evaluation of the different populations of lymphoid and myeloid cells in the peripheral blood of patients treated with chemoradiotherapy for head and neck cancer. Cancer Immunol. Immunother. 73, 222 (2024).","journal-title":"Cancer Immunol. Immunother."},{"key":"1658_CR17","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1007\/s00066-023-02122-5","volume":"199","author":"B Frey","year":"2023","unstructured":"Frey, B. et al. DNA as the main target in radiotherapy-a historical overview from first isolation to anti-tumour immune response. Strahlenther. Onkol. 199, 1080\u20131090 (2023).","journal-title":"Strahlenther. Onkol."},{"key":"1658_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.chembiol.2025.04.001","volume":"32","author":"E Guilbaud","year":"2025","unstructured":"Guilbaud, E., Naulin, F., Meziani, L., Deutsch, E. & Galluzzi, L. Impact of radiation therapy on the immunological tumor microenvironment. Cell Chem. Biol. 32, 678\u2013693 (2025).","journal-title":"Cell Chem. Biol."},{"key":"1658_CR19","doi-asserted-by":"publisher","first-page":"1148692","DOI":"10.3389\/fimmu.2023.1148692","volume":"14","author":"C Iliadi","year":"2023","unstructured":"Iliadi, C. et al. The current understanding of the immune landscape relative to radiotherapy across tumor types. Front. Immunol. 14, 1148692 (2023).","journal-title":"Front. Immunol."},{"key":"1658_CR20","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1158\/1078-0432.CCR-18-0871","volume":"25","author":"S Miyauchi","year":"2019","unstructured":"Miyauchi, S. et al. Immune modulation of head and neck squamous cell carcinoma and the tumor microenvironment by conventional therapeutics. Clin. Cancer Res. 25, 4211\u20134223 (2019).","journal-title":"Clin. Cancer Res."},{"key":"1658_CR21","unstructured":"Lundberg, S.M. & Lee, S.-I. A Unified Approach to Interpreting Model Predictions. In Proc. 31st International Conference on Neural Information Processing Systems, 4768-4777, https:\/\/neurips.cc\/ (2017)."},{"key":"1658_CR22","doi-asserted-by":"publisher","first-page":"1447123","DOI":"10.3389\/fonc.2024.1447123","volume":"14","author":"M Haderlein","year":"2024","unstructured":"Haderlein, M. et al. De-intensification of postoperative radiotherapy in head and neck cancer irrespective of human papillomavirus status-results of a prospective multicenter phase II trial (DIREKHT Trial). Front. Oncol. 14, 1447123 (2024).","journal-title":"Front. Oncol."},{"key":"1658_CR23","doi-asserted-by":"publisher","unstructured":"Zumsteg, Z. S. et al. Re-examining post-operative chemoradiotherapy in head and neck cancer: an updated long-term combined analysis of RTOG 9501\/EORTC 22931. Ann. Oncol. https:\/\/doi.org\/10.1016\/j.annonc.2025.07.004 (2025).","DOI":"10.1016\/j.annonc.2025.07.004"},{"key":"1658_CR24","doi-asserted-by":"publisher","unstructured":"Magnes, T. et al. Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22094981 (2021).","DOI":"10.3390\/ijms22094981"},{"key":"1658_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-49771-0","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma. Sci. Rep. 9, 13404 (2019).","journal-title":"Sci. Rep."},{"key":"1658_CR26","doi-asserted-by":"publisher","unstructured":"Conarty, J. P. & Wieland, A. The tumor-specific immune landscape in HPV+ head and neck cancer. Viruses 15, https:\/\/doi.org\/10.3390\/v15061296 (2023).","DOI":"10.3390\/v15061296"},{"key":"1658_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-023-01157-9","volume":"28","author":"X Gan","year":"2023","unstructured":"Gan, X., Gou, Q., Zhu, J. & Zhang, T. Dynamic change of the systemic immune inflammation index is a risk factor for patients with oropharyngeal cancer: a case control study and an additional HPV-status subgroup analysis. Eur. J. Med. Res. 28, 191 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"1658_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s00066-019-01529-3","volume":"196","author":"D Ou","year":"2020","unstructured":"Ou, D. et al. Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma. Strahlenther. Onkol. 196, 252\u2013261 (2020).","journal-title":"Strahlenther. Onkol."},{"key":"1658_CR29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.anl.2016.05.013","volume":"44","author":"DY Kim","year":"2017","unstructured":"Kim, D. Y. et al. Prognostic value of posttreatment neutrophil-lymphocyte ratio in head and neck squamous cell carcinoma treated by chemoradiotherapy. Auris Nasus Larynx 44, 199\u2013204 (2017).","journal-title":"Auris Nasus Larynx"},{"key":"1658_CR30","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1111\/cas.14816","volume":"112","author":"K Piersiala","year":"2021","unstructured":"Piersiala, K. et al. CD4(+) and CD8(+) T cells in sentinel nodes exhibit distinct pattern of PD-1, CD69, and HLA-DR expression compared to tumor tissue in oral squamous cell carcinoma. Cancer Sci. 112, 1048\u20131059 (2021).","journal-title":"Cancer Sci."},{"key":"1658_CR31","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/ijc.34281","volume":"152","author":"Y Peng","year":"2023","unstructured":"Peng, Y. et al. CD25: a potential tumor therapeutic target. Int. J. Cancer 152, 1290\u20131303 (2023).","journal-title":"Int. J. Cancer"},{"key":"1658_CR32","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/nm.4466","volume":"24","author":"C Krieg","year":"2018","unstructured":"Krieg, C. et al. High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy. Nat. Med. 24, 144\u2013153 (2018).","journal-title":"Nat. Med."},{"key":"1658_CR33","doi-asserted-by":"publisher","first-page":"e13343","DOI":"10.1111\/aji.13343","volume":"85","author":"AE Stenzel","year":"2021","unstructured":"Stenzel, A. E. et al. Circulating CD14(+) HLA-DR(lo\/-) monocytic cells as a biomarker for epithelial ovarian cancer progression. Am. J. Reprod. Immunol. 85, e13343 (2021).","journal-title":"Am. J. Reprod. Immunol."},{"key":"1658_CR34","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.3389\/fimmu.2019.01147","volume":"10","author":"AE Mengos","year":"2019","unstructured":"Mengos, A. E., Gastineau, D. A. & Gustafson, M. P. The CD14(+)HLA-DR(lo\/neg) monocyte: an immunosuppressive phenotype that restrains responses to cancer immunotherapy. Front. Immunol. 10, 1147 (2019).","journal-title":"Front. Immunol."},{"key":"1658_CR35","doi-asserted-by":"publisher","first-page":"1451035","DOI":"10.3389\/fonc.2024.1451035","volume":"14","author":"AJ Donaubauer","year":"2024","unstructured":"Donaubauer, A. J. et al. Defining intra-tumoral and systemic immune biomarkers for locally advanced head-and-neck cancer - detailed protocol of a prospective, observatory multicenter trial (ImmunBioKHT) and first results of the immunophenotyping of the patients\u2019 peripheral blood. Front. Oncol. 14, 1451035 (2024).","journal-title":"Front. Oncol."},{"key":"1658_CR36","doi-asserted-by":"publisher","first-page":"1747345","DOI":"10.1080\/2162402X.2020.1747345","volume":"9","author":"SK Bisheshar","year":"2020","unstructured":"Bisheshar, S. K., De Ruiter, E. J., Devriese, L. A. & Willems, S. M. The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oncoimmunology 9, 1747345 (2020).","journal-title":"Oncoimmunology"},{"key":"1658_CR37","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/hed.24986","volume":"40","author":"Y Takenaka","year":"2018","unstructured":"Takenaka, Y. et al. Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: a meta-analysis. Head. Neck 40, 647\u2013655 (2018).","journal-title":"Head. Neck"},{"key":"1658_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-01457-6","volume":"15","author":"Y Qin","year":"2025","unstructured":"Qin, Y. et al. Peripheral eosinophils and immunotherapy response in patients with recurrent or metastatic HNSCC. Sci. Rep. 15, 17351 (2025).","journal-title":"Sci. Rep."},{"key":"1658_CR39","doi-asserted-by":"publisher","first-page":"1287178","DOI":"10.3389\/fonc.2024.1287178","volume":"14","author":"F Jungbauer","year":"2024","unstructured":"Jungbauer, F. et al. Risk factors for immune-related adverse effects during CPI therapy in patients with head and neck malignancies - a single center study. Front. Oncol. 14, 1287178 (2024).","journal-title":"Front. Oncol."},{"key":"1658_CR40","doi-asserted-by":"publisher","first-page":"191602162513182","DOI":"10.1177\/19160216251318255","volume":"54","author":"Z Hu","year":"2025","unstructured":"Hu, Z. et al. Nomogram prediction of response to neoadjuvant chemotherapy plus pembrolizumab in locally advanced hypopharyngeal squamous cell carcinoma. J. Otolaryngol. Head. Neck Surg. 54, 19160216251318255 (2025).","journal-title":"J. Otolaryngol. Head. Neck Surg."},{"key":"1658_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-95718-9","volume":"11","author":"I Mito","year":"2021","unstructured":"Mito, I. et al. Comprehensive analysis of immune cell enrichment in the tumor microenvironment of head and neck squamous cell carcinoma. Sci. Rep. 11, 16134 (2021).","journal-title":"Sci. Rep."},{"key":"1658_CR42","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1158\/1078-0432.CCR-19-3195","volume":"26","author":"NL Goerig","year":"2020","unstructured":"Goerig, N. L. et al. Early mortality of brain cancer patients and its connection to cytomegalovirus reactivation during radiochemotherapy. Clin. Cancer Res. 26, 3259\u20133270 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1658_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00066-024-02272-0","volume":"201","author":"Y Huang","year":"2025","unstructured":"Huang, Y. et al. Principles of artificial intelligence in radiooncology. Strahlenther. Onkol. 201, 210\u2013235 (2025).","journal-title":"Strahlenther. Onkol."},{"key":"1658_CR44","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00066-024-02281-z","volume":"201","author":"A Zwanenburg","year":"2025","unstructured":"Zwanenburg, A., Price, G. & Lock, S. Artificial intelligence for response prediction and personalisation in radiation oncology. Strahlenther. Onkol. 201, 266\u2013273 (2025).","journal-title":"Strahlenther. Onkol."},{"key":"1658_CR45","doi-asserted-by":"publisher","unstructured":"Haderlein, M. et al. Dose reduction to the swallowing apparatus and the salivary glands by de-intensification of postoperative radiotherapy in patients with head and neck cancer: first (treatment planning) results of the prospective multicenter DIREKHT trial. Cancers 12, https:\/\/doi.org\/10.3390\/cancers12030538 (2020).","DOI":"10.3390\/cancers12030538"},{"key":"1658_CR46","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/ijms17081316","volume":"17","author":"PF R\u00fchle","year":"2016","unstructured":"R\u00fchle, P. F., Fietkau, R., Gaipl, U. S. & Frey, B. Development of a modular assay for detailed immunophenotyping of peripheral human whole blood samples by multicolor flow cytometry. Int. J. Mol. Sci. 17, 1316 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"1658_CR47","unstructured":"Mardia, K. V. K., J. T.; Bibby, J. M. Multivariate Analysis (Elsevier Science & Technology, 1979)."},{"key":"1658_CR48","doi-asserted-by":"publisher","first-page":"152333","DOI":"10.1109\/ACCESS.2021.3126429","volume":"9","author":"A Jenul","year":"2021","unstructured":"Jenul, A. et al. RENT-repeated elastic net technique for feature selection. IEEE Access 9, 152333\u2013152346 (2021).","journal-title":"IEEE Access"},{"key":"1658_CR49","doi-asserted-by":"publisher","unstructured":"Jenul, A., Schrunner, S., Huynh, B. N. & Tomic, O. RENT: a Python package for repeated elastic net feature selection. J. Open Source Softw. 6, https:\/\/doi.org\/10.21105\/joss.03323 (2021).","DOI":"10.21105\/joss.03323"},{"key":"1658_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-91","volume":"7","author":"S Varma","year":"2006","unstructured":"Varma, S. & Simon, R. Bias in error estimation when using cross-validation for model selection. BMC Bioinforma. 7, 91 (2006).","journal-title":"BMC Bioinforma."},{"key":"1658_CR51","first-page":"2079","volume":"11","author":"GC Cawley","year":"2010","unstructured":"Cawley, G. C. & Talbot, N. L. C. On over-fitting in model selection and subsequent selection bias in performance evaluation. J. Mach. Learn Res. 11, 2079\u20132107 (2010).","journal-title":"J. Mach. Learn Res."},{"key":"1658_CR52","unstructured":"T., H., R., T. & J., F. The Elements of Statistical Learning (Springer Nature Link, 2009)."},{"key":"1658_CR53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1023\/A:1022627411411","volume":"20","author":"C Cortes","year":"1995","unstructured":"Cortes, C. & Vapnik, V. Support-vector networks. Mach. Learn. 20, 273\u2013297 (1995).","journal-title":"Mach. Learn."},{"key":"1658_CR54","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining 785\u2013794 (Association for Computing Machinery, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"1658_CR55","doi-asserted-by":"publisher","first-page":"vbad048","DOI":"10.1093\/bioadv\/vbad048","volume":"3","author":"MJ Lewis","year":"2023","unstructured":"Lewis, M. J. et al. nestedcv: an R package for fast implementation of nested cross-validation with embedded feature selection designed for transcriptomics and high-dimensional data. Bioinform Adv. 3, vbad048 (2023).","journal-title":"Bioinform Adv."},{"key":"1658_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-025-02709-9","volume":"25","author":"A Dubray-Vautrin","year":"2025","unstructured":"Dubray-Vautrin, A. et al. A clustering-stratified cross-validation framework for validating omics survival models: application to head and neck cancer. BMC Med. Res. Methodol. 25, 277 (2025).","journal-title":"BMC Med. Res. Methodol."},{"key":"1658_CR57","doi-asserted-by":"crossref","unstructured":"Akiba, T., Sano, S., Yanase, T., Ohta, T. & Koyama, M. in Proceedings of the 25th ACM SIGKDD International Conference on Knowledge Discovery & Data Mining 2623\u20132631 (Association for Computing Machinery, 2019).","DOI":"10.1145\/3292500.3330701"},{"key":"1658_CR58","unstructured":"Lavazza, L. M., S.; Rotoloni, G. in International Conference on Evaluation and Assessment in Software Engineering, 8 (ACM, 2023)."},{"key":"1658_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-023-00322-4","volume":"16","author":"D Chicco","year":"2023","unstructured":"Chicco, D. & Jurman, G. The Matthews correlation coefficient (MCC) should replace the ROC AUC as the standard metric for assessing binary classification. BioData Min. 16, 4 (2023).","journal-title":"BioData Min."}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01658-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01658-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T01:03:48Z","timestamp":1788224628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01658-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1658"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01658-w","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"337"}}